Evaluation of Cost-Effectiveness of Adjuvant Osimertinib in Patients with Resected EGFR Mutation-Positive Non-small Cell Lung Cancer
评估奥希替尼辅助治疗对切除术后EGFR突变阳性非小细胞肺癌患者的成本效益
期刊:Pharmacoeconomics-Open
影响因子:2.1
doi:10.1007/s41669-023-00396-0
Verhoek, Andre; Cheema, Parneet; Melosky, Barbara; Samson, Benoit; Shepherd, Frances A; de Marinis, Filippo; John, Thomas; Wu, Yi-Long; Heeg, Bart; Van Dalfsen, Nadia; Bracke, Benjamin; Miranda, Miguel; Shaw, Simon; Moldaver, Daniel